Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Mecoli

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Rheumatology|July 3, 2018
Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi StudyJin Kyun Park, Christopher A. Mecoli, Helene Alexanderson, et al.
The Journal of Rheumatology|August 3, 2017
Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi StudyJin Kyun Park, Christopher A Mecoli, Helene Alexanderson, et al.
Arthritis Care & Research|September 11, 2025
The Effect of Pulmonary Function Test Reference Equations on Classification of Restrictive Lung Disease Severity in Systemic SclerosisKamini E Kuchinad, Rachel S Wallwork, Matthew R Lammi, et al.
The Journal of Rheumatology|December 3, 2017
Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi StudyJin Kyun Park, Christopher A. Mecoli, Helene Alexanderson, et al.
Clinical and Experimental Rheumatology|February 24, 2023
Anti-MDA5-positive dermatomyositis and remission in a single referral centre populationEleni Tiniakou, Christopher A Mecoli, William Kelly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2023
Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive DermatomyositisDavid Fiorentino, Christopher A Mecoli, Tak Igusa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 21, 2019
Myositis Autoantibodies: A Comparison of Results From the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line BlotChristopher A Mecoli, Jemima Albayda, Eleni Tiniakou, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Anti-TRIM72 Autoantibodies in Idiopathic Inflammatory MyopathiesEugene Krustev, Tiara N Safaei, Daniela Trejo-Zambrano, et al.
Neurology|January 23, 2023
Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body MyositisElizabeth Harlan Michelle, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
The Journal of Rheumatology|September 17, 2018
Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT StudyChristopher A Mecoli, Jin Kyun Park, Helene Alexanderson, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Rheumatology|July 3, 2018
Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi StudyJin Kyun Park, Christopher A. Mecoli, Helene Alexanderson, et al.
The Journal of Rheumatology|August 3, 2017
Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi StudyJin Kyun Park, Christopher A Mecoli, Helene Alexanderson, et al.
Arthritis Care & Research|September 11, 2025
The Effect of Pulmonary Function Test Reference Equations on Classification of Restrictive Lung Disease Severity in Systemic SclerosisKamini E Kuchinad, Rachel S Wallwork, Matthew R Lammi, et al.
The Journal of Rheumatology|December 3, 2017
Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi StudyJin Kyun Park, Christopher A. Mecoli, Helene Alexanderson, et al.
Clinical and Experimental Rheumatology|February 24, 2023
Anti-MDA5-positive dermatomyositis and remission in a single referral centre populationEleni Tiniakou, Christopher A Mecoli, William Kelly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2023
Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive DermatomyositisDavid Fiorentino, Christopher A Mecoli, Tak Igusa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 21, 2019
Myositis Autoantibodies: A Comparison of Results From the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line BlotChristopher A Mecoli, Jemima Albayda, Eleni Tiniakou, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Anti-TRIM72 Autoantibodies in Idiopathic Inflammatory MyopathiesEugene Krustev, Tiara N Safaei, Daniela Trejo-Zambrano, et al.
Neurology|January 23, 2023
Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body MyositisElizabeth Harlan Michelle, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
The Journal of Rheumatology|September 17, 2018
Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT StudyChristopher A Mecoli, Jin Kyun Park, Helene Alexanderson, et al.
Pageof 8